Actos News | Bladder Cancer
Actos News
  • Troy Rafferty of Levin, Papantonio Selected for Team of Attorneys to Lead Actos Litigation

    Actos MDL Judge Appoints Troy Rafferty to the Plaintiffs Steering Committee

    The Actos MDL (2299) is in full force. The Initial Status Conference will be this week on Thursday, March 22nd.  Judge Rebecca Doherty of the United States District Court, Western District of Louisiana has made her selections for the Plaintiffs’ Executive Committee and Steering Committee.  Judge Doherty selected Troy Rafferty to be part of the twelve-member Plaintiffs’ Steering Committee and announced this appointment on the Western District’s website last week.  You can view In Re: Actos (Pioglitazone) Products Liability Litigation (MDL 2299) announcements, orders, and other information on the MDL site: http://www.lawd.uscourts.gov/MDL2299/index.html

    read more
  • Actos - Bad News For Some

    Type 1 (childhood onset) and Type 2 (adult onset) diabetes are really two different diseases with completely different causes. There is some commonality between the respective disorders, however.  When untreated, he health consequences can be the same – eye damage (diabetic retinopathy), circulation issues in the extremities, kidney disease, etc.

    read more
  • From Twice a Day to Once a Week – Is It Better?

    Exanatide is an alternative treatment for type 2 diabetes that has been around for awhile. Unlike Actos and Avandia – which work by trying to make cells more sensitive to insulin – exanatide works directly on the pancreas by trying to get that organ to produce more insulin.

     

    read more
  • More Evidence That You Might Not Need Their Meds

    This news probably have the makers of Actos, Avandia and other diabetic drugs pitching a fit.

     

    After all, nothing is as threatening to their bloated profit margins as the idea that simply going on a calorie-restricted diet can reverse Type 2 diabetes.

     

    read more
  • Jobs Are Not All We Are Exporting

    A recent report now indicates that the market for diabetic drugs is poised to grow by almost 120% over the next four years – something that has Big Pharma doing the Happy Dance.  Not surprisingly, the U.S., whose completely evil and inhuman profit-driven health care system – controlled by equally inhuman monsters who would gleefully devour their own children if it would raise their corporatations' stock price by even two percent even as they murder 45,000 Americans every year – has been the major source of these profits. (Compare this number to the 3,000 who died on 11 September 2001. What was that about “death panels” again?)

    read more
  • Maybe You Don't Need Drugs

    Bryan Helm. who works for the Cape May-Lewes Ferry in Ocean City New Jersey, has his Type-2 diabetes under tight control - the best outcome possible for such patients.  First diagnosed over a year ago, Helm began attending classes at a local diabetes center. Here, he was taught what was referred to as the "four aspects of control":

    read more
  • Actos: Why the Difference?

    The risk factors for Type 2 diabetes are well known, but worth reviewing: primarily, these factors are obesity in combination with a sedentary lifestyle, and genetics.

     

    The last issue – genetics – play a larger role among some ethnic groups than others. In fact, people who have Native American ancestry are over twice as like likely to develop Type 2 diabetes than those of European descent, simply because they are Native American. According to a Cherokee Nation newspaper, a whopping 30% of people of American Indian or Inuit extraction are pre-diabetic.

     

    Why?

    read more
  • Actos: Is Two Better Than One?

    At the end of September, I reported on a "new" drug from Actos maker Takeda pharmaceutical, which is currently marketed outside the U.S. as Nesina. It is not actually new; it is a combination of Actos and another anti-diabetic drug, alogliptin. which was submitted to the FDA for approval in late 2007, but withdrawn the following year after the FDA determined that additional data was needed.

     

    read more
  • Guilty As Charged...But Still Smelling Like a Rose

    "Corporations are people, my friend." - GOP presidential candidate Mitt Romney

     

    We must give Mr. Romney credit for so openly declaring what most 99% of Americans have long suspected and what the inexcusable Citizens United v. FEC decision made abundantly clear. The question that so many of us have however is that if corporations are people with human rights of free speech, how come they can't be put in jail like natural humans? How come they don't face criminal charges like human felons when they steal and commit murder?

     

    read more

Pages